# AL101 Before Surgery for the Treatment of Notch Activated Adenoid Cystic Cancer

> **NCT04973683** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **M.D. Anderson Cancer Center** · enrollment: 14 (estimated)

## Conditions studied

- Adenoid Cystic Carcinoma
- Metastatic Adenoid Cystic Carcinoma

## Interventions

- **DRUG:** AL101
- **PROCEDURE:** Therapeutic Conventional Surgery

## Key facts

- **NCT ID:** NCT04973683
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-09-30
- **Primary completion:** 2028-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 14 (ESTIMATED)
- **Last updated:** 2026-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04973683

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04973683, "AL101 Before Surgery for the Treatment of Notch Activated Adenoid Cystic Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04973683. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*